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Supplemental Fig. 1:  Time-­‐course of lipin-­‐1 silencing. Western blot analysis of whole-­‐cell 
lysates of PC-­‐3 cells transfected with the indicated siRNA. Cells were processed between day  
2 and 5 after transfection and analyzed by immunoblotting with specific antibodies to lipin-­‐1 
and Erk1/2. Representative blots are shown.  
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Supplemental Fig.2: FACS analysis was performed after labeling PC-­‐3 cells with FITC-­‐annexin 
V (FITC-­‐A, X-­‐axes) and propidium iodide (PI, Y-­‐axes). 10.000 events were collected for each 
experiment. (A) Example of dots graphs of control cells (siScr) and cells depleted in lipin-­‐1  
(siLipin1). Alive cells [Q3] (double negative staining), cells in early apoptosis [Q4] (annexin V 
positive, PI negative), in late apoptosis [Q2] (double positive) and necrotic [Q1] (annexin V 
negative, PI positive) are indicated on the graphs. (B) Percentages of living / dead cells 
measured by FACS analysis. The dead cells include necrotic cells + early and late apoptotic 
cells.  The graph summarizes the results of three independent experiments expressed as the 
mean+s.d.  
  
  
  
 
  
  
  
  
Supplemental Fig. 3:  Lipin-­‐1 silencing inhibits PC-­‐3 cells proliferation as determined by cell 
counting. Immediately after transfection with a control siRNA (Scr) or with a siRNA targeting 
lipin-­‐1 (siLipin1(1) or siLipin1(2)) cells were seeded in 12-­‐well plates and collected at the 
indicated times after trypsin-­‐EDTA treatment. The number of cells in each well was 
measured as described in ?Materials and Method??? ***: p< 0.001 as determined by ANOVA 
followed by Tukey-­‐Kramer analysis.  
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Supplemental Fig.4: The inhibition of proliferation following lipin-­‐1 silencing is observed in 
normal and in lipid-­‐free medium. Cells (PC-­‐3, prostate adenocarcinoma; Hs578T, breast 
adenocarcinoma) were transfected with control (triangles) or lipin-­‐1 specific (squares) siRNA 
and cultured in normal medium (black symbols) or in medium supplemented with lipid-­‐free 
serum (open symbols). The DNA content of each well was measured as described in 
?Materials and Methods?? *** p< 0.001 ANOVA followed by Tukey-­‐Kramer analysis.  
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Supplemental Fig.5. The inhibition of proliferation following lipin-­‐1 silencing is not rescued 
by RhoA silencing. Immediately after transfection with control siRNA + RhoA siRNA (Scr+siA1) 
or with lipin-­‐1 siRNA + RhoA siRNA (siLipin1+siA1), cells were seeded in 24-­‐wells plates and 
collected at the indicated times. The DNA content of each well was measured as described in 
?Materials and Methods?? *** p< 0.001 ANOVA followed by Tukey-­‐Kramer analysis.  
   
  
Supplemental Fig.6. Lipin-­‐1 silencing does not significantly affect lipid synthesis, triglycerides 
content or Fatty Acid Synthase (FASN) expression but increased Phosphatidic Acid (PA) 
content. PC-­‐3 cells were transfected with the indicated siRNA. (A) 24   h after transfection, 
cells were incubated with 3H-­‐acetate for 24  h. Cells were then collected and processed for 
measuring the 3H-­‐acetate incorporated into the lipid phase as described in ?Material and 
Methods?. The results are representative of three independent experiments. (B) 48  h after 
transfection, cells were collected, lipids extracted and triglycerides measured as described in 
?Materials and Method??? (C-­‐D) Total RNA was extracted 48  h after transfection. Fatty Acid 
Synthase (FASN) (C) and ATP citrate lyase (ACLY) (D) mRNA were amplified by RT-­‐ PCR. Data 
are expressed in arbitrary  units  (A.U.)  relatively to the control condition set up to 100.  (E) 
48   h after transfection, cells were processed for Phosphatidic Acid measurements as 
described in ?Materials and Methods?? The results of each graph are the mean+s.d. of three 
independent experiments. *p<0.05 ANOVA followed by Tukey-­‐Kramer analysis.  
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Supplemental Fig. 7. Compensatory regulations between lipin-­‐1 and -­‐2 in Hs578T cells but 
not in PNT1A cells or fibroblasts. 48 h after transfection with the indicated siRNA, cells were 
lysed and analyzed by Western blotting with specific antibodies to lipin-­‐1, lipin-­‐2 and Erk1/2. 
Representative blots are shown.  
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Supplemental Fig.8. The inhibition of migration mediated by lipin-­‐1 silencing is not altered 
following co-­‐silencing lipin-­‐2. Immediately after transfection with 20  nM of a control siRNA,  
20   nM of the first siRNA targeting lipin-­‐1 (siLipin1) or 20   nM of the first siRNA targeting 
lipin-­‐1+20  nM of an siRNA targeting lipin-­‐2 (siLipin1+siLipin2) cells were processed for the 
wound healing assay as described in ?Materials and Method??? Representative phase 
contrast microscopy photographs were taken immediately after releasing the insert (0h) and 
16 hours later (16h). Bar = 250   µm. N.S.: not significant ***p<0.001 ANOVA followed by 
Tukey-­‐Kramer analysis. The graphs summarize the results of three independent experiments.  
   
  
  
  
  
  
  
  
  
  
Supplemental Fig. 9. Potentiation of the anti-­‐proliferative effect of rapamycin by 
pharmacological inhibition of lipin-­‐1 as determined by direct cell counting. PC-­‐3 cells seeded 
in 12-­‐well plates were treated with 50   nM rapamycin (rapa) and/or 100 µM propranolol 
(propr). The number of cells in each well was measured as described in ?Materials and 
Method???        *** p< 0.001 ANOVA followed by Tukey-­‐Kramer analysis.  
 
  
  
  
Supplemental Fig.10. Western blot analyses of PC-­‐3 cells lysates with specific antibodies to 
Lipin-­‐1 and Erk1/2. In (A), cells were cultured in presence of the indicated concentration of 
rapamycin or vehicle (0) during 24  h. The shift down of the band corresponding to lipin-­‐1 
suggests a decreased phosphorylation of the protein. In (B), cells were cultured with (+) or 
without (-­‐) serum during 24 h. The graph below summarizes the results of three 
independent experiments expressed as mean+s.d. In (C), cells were cultured in presence of 
the indicated concentration of 1,2-­‐Dioctanoyl-­‐sn-­‐glycerol 3-­‐phosphate sodium salt (di8-­‐PA) 
during 24  h. ***p<0.001 ANOVA followed by Tukey-­‐Kramer analysis.  
